HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Klotho restrain RIG-1/NF-κB signaling activation and monocyte inflammatory factor release under uremic condition.

AbstractAIMS:
Systemic inflammation is a main hallmark of chronic kidney disease (CKD), but the underlying mechanisms of pathogenesis of CKD-associated systemic inflammation is unclear. Current study was designed to investigate the relationship between indoxyl sulphate (IS) and CKD-associated systemic inflammation along with the protective effects of Klotho in CKD.
METHODS:
IS serum levels from patients were detected by high-performance liquid chromatography (HPLC), and Serum Klotho, IL-6 and TNF-α were measured separately by ELISA and Real-Time PCR analysis. Monocytes were incubated with or without Klotho, while the expressions of retinoic acid-inducible gene I (RIG-I) and NF-κB were analyzed through Western blot assay. Heterozygous kl/kl (kl/+) mice or WT mice were treated with 5/6 renal damage. Thereafter, the CKD mice were intraperitoneally injected with recombinant Klotho protein or PBS.
KEY FINDINGS:
It shows that in 286 CKD patients, the serum levels of inflammatory factors were positively related with IS, but negatively related with Klotho. Klotho significantly inhibited IS-induced RIG-I/NF-κB activation and productions of both IL-6 and TNF-α in cultured monocytes. In vivo, along with the increase of IS and decrease of Klotho in the serum, the activation of RIG-I/NF-κB signaling was observed in peripheral blood monocytes in both CKD mice and patients. Notably, higher levels of IL-6 and TNF-α were detected in kl+/- mice given CKD. Klotho administration has evidently attenuated RIG-I/NF-κB activation in monocytes and systemic inflammation in CKD mice.
SIGNIFICANCE:
The findings suggest that Klotho can suppress CKD-associated systemic inflammation through inhibiting IS-induced RIG-1/NF-κB activation and monocyte inflammatory factor release.
AuthorsTing He, Jiachuan Xiong, Yinghui Huang, Changling Zheng, Yong Liu, Xianjin Bi, Chi Liu, Wenhao Han, Ke Yang, Tangli Xiao, Xinli Xu, Yanlin Yu, Yunjian Huang, Jingbo Zhang, Bo Zhang, Jinghong Zhao
JournalLife sciences (Life Sci) Vol. 231 Pg. 116570 (Aug 15 2019) ISSN: 1879-0631 [Electronic] Netherlands
PMID31207307 (Publication Type: Journal Article)
CopyrightCopyright © 2019 Elsevier Inc. All rights reserved.
Chemical References
  • Interleukin-6
  • NF-kappa B
  • Receptors, Immunologic
  • Tumor Necrosis Factor-alpha
  • Glucuronidase
  • Klotho Proteins
  • RIGI protein, human
  • DEAD Box Protein 58
  • Indican
Topics
  • Adult
  • Animals
  • Blotting, Western
  • DEAD Box Protein 58 (blood)
  • Female
  • Glucuronidase (blood, pharmacology)
  • Humans
  • Indican (blood)
  • Inflammation (blood, pathology)
  • Interleukin-6 (blood)
  • Kidney (metabolism)
  • Klotho Proteins
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Middle Aged
  • Monocytes (metabolism, pathology)
  • NF-kappa B (blood)
  • Receptors, Immunologic
  • Renal Insufficiency, Chronic (blood, pathology)
  • Signal Transduction
  • THP-1 Cells
  • Tumor Necrosis Factor-alpha (blood)
  • Uremia (blood, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: